本頁面由Tiger Trade Technology Pte. Ltd.提供服務

德康醫療

83.03
-1.4800-1.75%
盤後83.030.00000.00%19:39 EDT
成交量:254.74萬
成交額:2.12億
市值:313.32億
市盈率:32.74
高:85.82
開:84.65
低:82.83
收:84.51
52周最高:92.59
52周最低:54.11
股本:3.77億
流通股本:3.76億
量比:0.64
換手率:0.68%
股息:- -
股息率:- -
每股收益(TTM):2.54
每股收益(LYR):2.09
淨資產收益率:38.49%
總資產收益率:10.33%
市淨率:11.95
市盈率(LYR):39.74

資料載入中...

2024/03/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/08

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities